The application of silver nano-particles on developing potential treatment for chronic rhinosinusitis: Antibacterial action and cytotoxicity effect on human nasal epithelial cell model

Shyuan Yow Chen, Min Tsan Huang, Sylvia L.F. Pender, Muhammad Ruslin, Hsin Hua Chou, Keng Liang Ou

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Chronic rhinosinusitis (CRS) has raised attentions both in many countries due to its high relapsing rate and the resistance of certain treatments especially antibiotics application on both acute and chronic bacterial rhinosinusitis. The aim of this research is stressing on developing an effective alternative treatment for treating CRS and reducing the use of antibiotics to avoid further resistance forming. The antibacterial functions of silver nano-particles (AgNPs) are well known according to previous reports and studies. However, for developing a suitable treatment for further clinical application, a variety of AgNPs cell cytotoxicity experiments and AgNPs antibacterial properties experiments were examined in vitro in this study. For imitating the clinical condition of CRS, the human nasal epithelial cell line (RPMI2650) has chosen as experimental model. Moreover, Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) were selected for antibacterial function experiments. The analytical results demonstrated that 5 ppm of AgNPs not only maintains > 80% of cell activity to RPMI2650, but also possesses > 80% of antibacterial function to S. aureus and 100% of antibacterial function to E. coli. Therefore, 5 ppm of AgNPs might be considered as a promising antibacterial agent for treating CRS.

Original languageEnglish
Pages (from-to)624-630
Number of pages7
JournalMaterials Science and Engineering C
Volume80
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Cytotoxicity
Silver
silver
staphylococcus
antibiotics
Antibiotics
Escherichia
Anti-Bacterial Agents
Escherichia coli
Bactericides
Experiments
cells
cultured cells
Epithelial Cells

Keywords

  • Antibacterial agent
  • Chronic rhinosinusitis
  • Cytotoxicity
  • Human nasal epithelial cell
  • Silver nano-particles

ASJC Scopus subject areas

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

The application of silver nano-particles on developing potential treatment for chronic rhinosinusitis : Antibacterial action and cytotoxicity effect on human nasal epithelial cell model. / Chen, Shyuan Yow; Huang, Min Tsan; Pender, Sylvia L.F.; Ruslin, Muhammad; Chou, Hsin Hua; Ou, Keng Liang.

In: Materials Science and Engineering C, Vol. 80, 01.11.2017, p. 624-630.

Research output: Contribution to journalArticle

@article{bbe2e575bfd34917a0c2927422f07949,
title = "The application of silver nano-particles on developing potential treatment for chronic rhinosinusitis: Antibacterial action and cytotoxicity effect on human nasal epithelial cell model",
abstract = "Chronic rhinosinusitis (CRS) has raised attentions both in many countries due to its high relapsing rate and the resistance of certain treatments especially antibiotics application on both acute and chronic bacterial rhinosinusitis. The aim of this research is stressing on developing an effective alternative treatment for treating CRS and reducing the use of antibiotics to avoid further resistance forming. The antibacterial functions of silver nano-particles (AgNPs) are well known according to previous reports and studies. However, for developing a suitable treatment for further clinical application, a variety of AgNPs cell cytotoxicity experiments and AgNPs antibacterial properties experiments were examined in vitro in this study. For imitating the clinical condition of CRS, the human nasal epithelial cell line (RPMI2650) has chosen as experimental model. Moreover, Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) were selected for antibacterial function experiments. The analytical results demonstrated that 5 ppm of AgNPs not only maintains > 80{\%} of cell activity to RPMI2650, but also possesses > 80{\%} of antibacterial function to S. aureus and 100{\%} of antibacterial function to E. coli. Therefore, 5 ppm of AgNPs might be considered as a promising antibacterial agent for treating CRS.",
keywords = "Antibacterial agent, Chronic rhinosinusitis, Cytotoxicity, Human nasal epithelial cell, Silver nano-particles",
author = "Chen, {Shyuan Yow} and Huang, {Min Tsan} and Pender, {Sylvia L.F.} and Muhammad Ruslin and Chou, {Hsin Hua} and Ou, {Keng Liang}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.msec.2017.03.189",
language = "English",
volume = "80",
pages = "624--630",
journal = "Materials Science and Engineering C",
issn = "0928-4931",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The application of silver nano-particles on developing potential treatment for chronic rhinosinusitis

T2 - Antibacterial action and cytotoxicity effect on human nasal epithelial cell model

AU - Chen, Shyuan Yow

AU - Huang, Min Tsan

AU - Pender, Sylvia L.F.

AU - Ruslin, Muhammad

AU - Chou, Hsin Hua

AU - Ou, Keng Liang

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Chronic rhinosinusitis (CRS) has raised attentions both in many countries due to its high relapsing rate and the resistance of certain treatments especially antibiotics application on both acute and chronic bacterial rhinosinusitis. The aim of this research is stressing on developing an effective alternative treatment for treating CRS and reducing the use of antibiotics to avoid further resistance forming. The antibacterial functions of silver nano-particles (AgNPs) are well known according to previous reports and studies. However, for developing a suitable treatment for further clinical application, a variety of AgNPs cell cytotoxicity experiments and AgNPs antibacterial properties experiments were examined in vitro in this study. For imitating the clinical condition of CRS, the human nasal epithelial cell line (RPMI2650) has chosen as experimental model. Moreover, Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) were selected for antibacterial function experiments. The analytical results demonstrated that 5 ppm of AgNPs not only maintains > 80% of cell activity to RPMI2650, but also possesses > 80% of antibacterial function to S. aureus and 100% of antibacterial function to E. coli. Therefore, 5 ppm of AgNPs might be considered as a promising antibacterial agent for treating CRS.

AB - Chronic rhinosinusitis (CRS) has raised attentions both in many countries due to its high relapsing rate and the resistance of certain treatments especially antibiotics application on both acute and chronic bacterial rhinosinusitis. The aim of this research is stressing on developing an effective alternative treatment for treating CRS and reducing the use of antibiotics to avoid further resistance forming. The antibacterial functions of silver nano-particles (AgNPs) are well known according to previous reports and studies. However, for developing a suitable treatment for further clinical application, a variety of AgNPs cell cytotoxicity experiments and AgNPs antibacterial properties experiments were examined in vitro in this study. For imitating the clinical condition of CRS, the human nasal epithelial cell line (RPMI2650) has chosen as experimental model. Moreover, Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli (E. coli) were selected for antibacterial function experiments. The analytical results demonstrated that 5 ppm of AgNPs not only maintains > 80% of cell activity to RPMI2650, but also possesses > 80% of antibacterial function to S. aureus and 100% of antibacterial function to E. coli. Therefore, 5 ppm of AgNPs might be considered as a promising antibacterial agent for treating CRS.

KW - Antibacterial agent

KW - Chronic rhinosinusitis

KW - Cytotoxicity

KW - Human nasal epithelial cell

KW - Silver nano-particles

UR - http://www.scopus.com/inward/record.url?scp=85023631383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023631383&partnerID=8YFLogxK

U2 - 10.1016/j.msec.2017.03.189

DO - 10.1016/j.msec.2017.03.189

M3 - Article

C2 - 28866209

AN - SCOPUS:85023631383

VL - 80

SP - 624

EP - 630

JO - Materials Science and Engineering C

JF - Materials Science and Engineering C

SN - 0928-4931

ER -